Long-term genome-wide blood RNA expression profiles yield novel molecular response candidates for IFN-beta-1b treatment in relapsing remitting MS. Goertsches RH, Hecker M, Koczan D, Serrano-Fernandez P, Moeller S, Thiesen H-J, Zettl UK Pharmacogenomics. 2010 Feb; 11(2):147-61. PMID: 20136355. Abstract CommentRecommendBookmarkWatch